Package | au.digitalhealth.cda.schema |
Type | ValueSet |
Id | CDAObservationInterpretation |
FHIR Version | R5 |
Source | http://ns.electronichealth.net.au/cda/https://build.fhir.org/ig/AuDigitalHealth/cda-au-schema/ValueSet-CDAObservationInterpretation.html |
URL | http://hl7.org/cda/stds/core/ValueSet/CDAObservationInterpretation |
Version | 1.0.0 |
Status | draft |
Date | 2025-07-21T22:05:27+00:00 |
Name | CDAObservationInterpretation |
Title | CDAObservationInterpretation |
Realm | au |
Authority | national |
Description | One or more codes providing a rough qualitative interpretation of the observation - limited to values available in original CDA |
StructureDefinition | |
Observation | Observation (CDA Class) |
ObservationRange | ObservationRange (CDA Class) |
au-Observation | ADHA Observation (CDA Class) |
au-ObservationRange | ADHA ObservationRange (CDA Class) |
CodeSystem | |
v3-ObservationInterpretation | ObservationInterpretation |
v3-ObservationInterpretation | ObservationInterpretation |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet CDAObservationInterpretation
http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation
Code | Display | Definition |
B | Better | The current result or observation value has improved compared to the previous result or observation value (the change is significant as defined in the respective test procedure). \[Note: This can be applied to quantitative or qualitative observations.\] |
D | Significant change down | The current result has decreased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). |
U | Significant change up | The current result has increased from the previous result for a quantitative observation (the change is significant as defined in the respective test procedure). |
W | Worse | The current result or observation value has degraded compared to the previous result or observation value (the change is significant as defined in the respective test procedure). \[Note: This can be applied to quantitative or qualitative observations.\] |
< | Off scale low | The result is below the minimum detection limit (the test procedure or equipment is the limiting factor). Synonyms: Below analytical limit, low off scale. |
> | Off scale high | The result is above the maximum quantifiable limit (the test procedure or equipment is the limiting factor). Synonyms: Above analytical limit, high off scale. |
A | Abnormal | The result or observation value is outside the reference range or expected norm (as defined for the respective test procedure). \[Note: Typically applies to non-numeric results.\] |
AA | Critical abnormal | The result or observation value is outside a reference range or expected norm at a level at which immediate action should be considered for patient safety (as defined for the respective test procedure). \[Note: Typically applies to non-numeric results. Analogous to critical/panic limits for numeric results.\] |
HH | Critical high | The result for a quantitative observation is above a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Above upper panic limits. |
LL | Critical low | The result for a quantitative observation is below a reference level at which immediate action should be considered for patient safety (as defined for the respective test procedure). Synonym: Below lower panic limits. |
H | High | The result for a quantitative observation is above the upper limit of the reference range (as defined for the respective test procedure). Synonym: Above high normal |
L | Low | The result for a quantitative observation is below the lower limit of the reference range (as defined for the respective test procedure). Synonym: Below low normal |
N | Normal | The result or observation value is within the reference range or expected norm (as defined for the respective test procedure). \[Note: Applies to numeric or non-numeric results.\] |
I | Intermediate | Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\] \[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\] \[Note 3: This class also indicates a "buffer zone," to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\] \[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
MS | moderately susceptible | The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. ***Deprecation Comment:*** This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012). |
R | Resistant | Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.\] \[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
S | Susceptible | Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2 \[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.\] \[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\] |
VS | very susceptible | The patient is considered as carrier based on the testing results. A carrier is an individual who carries an altered form of a gene which can lead to having a child or offspring in future generations with a genetic disorder. ***Deprecation Comment:*** This antimicrobial susceptibility test interpretation concept is recommended by OO to be deprecated as it is no longer recommended for use in susceptibility testing by CLSI (reference CLSI document M100-S22; Vol. 32 No.3; CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Jan 2012). |
{ "resourceType": "ValueSet", "id": "CDAObservationInterpretation", "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm", "valueInteger": 1, "_valueInteger": { "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom", "valueCanonical": "http://ns.electronichealth.net.au/cda/ImplementationGuide/au.digitalhealth.cda.schema" } ] } } ], "url": "http://hl7.org/cda/stds/core/ValueSet/CDAObservationInterpretation", "version": "1.0.0", "name": "CDAObservationInterpretation", "title": "CDAObservationInterpretation", "status": "draft", "experimental": false, "date": "2025-07-21T22:05:27+00:00", "description": "One or more codes providing a rough qualitative interpretation of the observation - limited to values available in original CDA", "compose": { "include": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation", "concept": [ { "code": "B" }, { "code": "D" }, { "code": "U" }, { "code": "W" }, { "code": "<" }, { "code": ">" }, { "code": "A" }, { "code": "AA" }, { "code": "HH" }, { "code": "LL" }, { "code": "H" }, { "code": "L" }, { "code": "N" }, { "code": "I" }, { "code": "MS" }, { "code": "R" }, { "code": "S" }, { "code": "VS" } ] } ] } }